Adial Pharmaceuticals, Inc. (ADIL)

Adial Pharmaceuticals Statistics

Total Valuation

ADIL has a market cap or net worth of $6.01 million. The enterprise value is $1.48 million.

Market Cap	6.01M
Enterprise Value	1.48M

Important Dates

The next estimated earnings date is Tuesday, March 3, 2026, before market open.

Earnings Date	Mar 3, 2026
Ex-Dividend Date	n/a

Share Statistics

ADIL has 27.78 million shares outstanding. The number of shares has increased by 199.69% in one year.

Current Share Class	27.78M
Shares Outstanding	27.78M
Shares Change (YoY)	+199.69%
Shares Change (QoQ)	+108.72%
Owned by Insiders (%)	0.45%
Owned by Institutions (%)	3.40%
Float	27.65M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.19
P/TBV Ratio	1.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.34

Current Ratio	4.34
Quick Ratio	3.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -155.01% and return on invested capital (ROIC) is -94.51%.

Return on Equity (ROE)	-155.01%
Return on Assets (ROA)	-79.36%
Return on Invested Capital (ROIC)	-94.51%
Return on Capital Employed (ROCE)	-174.35%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.50% in the last 52 weeks. The beta is 1.20, so ADIL's price volatility has been higher than the market average.

Beta (5Y)	1.20
52-Week Price Change	-77.50%
50-Day Moving Average	0.28
200-Day Moving Average	0.42
Relative Strength Index (RSI)	32.76
Average Volume (20 Days)	368,066

Short Selling Information

The latest short interest is 385,797, so 1.39% of the outstanding shares have been sold short.

Short Interest	385,797
Short Previous Month	407,422
Short % of Shares Out	1.39%
Short % of Float	1.40%
Short Ratio (days to cover)	1.24

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.85M
Pretax Income	-8.05M
Net Income	-8.05M
EBITDA	-7.85M
EBIT	-7.85M
Earnings Per Share (EPS)	-$0.70

Balance Sheet

The company has $4.61 million in cash and n/a in debt, with a net cash position of $4.61 million or $0.17 per share.

Cash & Cash Equivalents	4.61M
Total Debt	n/a
Net Cash	4.61M
Net Cash Per Share	$0.17
Equity (Book Value)	4.51M
Book Value Per Share	0.19
Working Capital	3.86M

Cash Flow

Operating Cash Flow	-6.62M
Capital Expenditures	n/a
Free Cash Flow	-6.62M
FCF Per Share	-$0.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ADIL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.69%
Shareholder Yield	-199.69%
Earnings Yield	-132.20%
FCF Yield	-108.72%

Analyst Forecast

The average price target for ADIL is $1.50, which is 593.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$1.50
Price Target Difference	593.48%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-52.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 7, 2023
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1